Furthermore, CHIP/ARCH has been associated with non-hematologic diseases and conditions including cardiovascular diseases and atherosclerosis and adverse clinical outcomes in non-hematological cancers [7,8] (Figure 1). This evidence concerns the gene STUB1 and atherosclerosis.